WeVote

Bill

Bill

SB 973

An Act amending the act of March 10, 1949 (P.L.30, No.14), known as the Public School Code of 1949, in terms and courses of study, providing for early human life development education.

2025-2026 Regular Session Introduced by Michele Brooks

Private health plans that already cover contraceptives must provide in-network, prescription-free coverage for OTC and emergency contraception at point-of-sale starting Jan 1, 2026

Referred to Education
0
WeVote Research Nonpartisan
Bill Summary · SB 973

SB 973 — Insurance: Required coverage for over‑the‑counter contraception and emergency contraception

Status and key dates
- Bill number: SB 973 (Substitute S-3 as reported)
- Sponsor: Senator Mary Cavanagh
- Introduced: Jan 29, 2025 (committee materials also show earlier Senate activity on substitute S‑3)
- Effective / implementation timing in bill text: coverage requirement begins January 1, 2026
- Committee: Health Policy
- Current procedural status (per materials provided): placed on second reading

Purpose / intent
- To increase access to contraception by requiring health insurers that already cover contraceptives to provide point‑of‑sale coverage at in‑network pharmacies for over‑the‑counter (OTC) contraception and emergency contraception without requiring a prescription.

Major provisions
- Insurer coverage requirement (beginning Jan 1, 2026): An insurer that delivers, issues, or renews a Michigan health insurance policy that provides coverage for contraceptives must provide coverage at an in‑network pharmacy for OTC contraception and emergency contraception without a prescription.
- Scope: Applies to insurers only where the health plan already provides contraceptive coverage.
- Definitions:
- "Contraception" — a drug, device, or other product covered on the insurer’s formulary that is FDA‑approved to prevent pregnancy; explicitly includes hormonal drugs administered orally, transdermally, or intravaginally.
- "Emergency contraception" — an FDA‑approved drug to prevent pregnancy after unprotected intercourse or suspected contraceptive failure.
- Administrative limits: Required coverage is subject to the insurer’s existing utilization management, prior authorization, quantity limit, or precertification rules.
- Enforcement/penalties: Existing Insurance Code enforcement provisions (administrative hearings and civil fines) may apply for violations.

Who would be affected
- Insurers: Health plans issued, delivered, or renewed in Michigan that currently cover contraceptives will need to provide point‑of‑sale, in‑network coverage for OTC and emergency contraceptives without a prescription.
- Insured individuals: Plan members would be able to obtain OTC contraception and emergency contraception at in‑network pharmacies without a prescription—potentially reducing out‑of‑pocket costs and barriers to access.
- Pharmacies and pharmacy networks: In‑network pharmacies will be the point of dispensing for covered OTC contraceptives; pharmacy billing and reimbursement processes may require adjustments.
- Medicaid (related bill SB 974): SB 973 addresses private insurance; a companion Senate bill (SB 974) would require Medicaid to cover OTC contraception without a prescription. Analyses flag that the Medicaid change could have a significant and uncertain fiscal impact.

Fiscal impact
- Nonpartisan Senate staff analysis: SB 973 would have no direct fiscal impact on State or local government.
- House Fiscal Agency notes: enforcement fines under the Insurance Code are possible (civil fines up to specified statutory caps), which could produce general fund receipts if violations occur.
- Medicaid (SB 974): Separately, expanding Medicaid access to dispense preferred‑list contraceptives without prescriptions could carry a significant fiscal cost to the Department of Health and Human Services; scope and cost are uncertain.

Practical effects and considerations
- Increases direct, pharmacy‑based access to OTC contraceptives and emergency contraception for people covered by private plans that already include contraceptive benefits.
- Insurer utilization controls remain available, which could affect practical access (prior authorization, quantity limits).
- Coordination needed between insurers and pharmacy networks to implement point‑of‑sale reimbursement for OTC products.
- Separate legislative or administrative action (SB 974) would be needed to create equivalent prescription‑free access for Medicaid enrollees; that change raises fiscal and operational questions for the Medicaid program.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.